PMID: 11926438Apr 3, 2002Paper

Antimicrobial susceptibility of Gram-positive bacteria: what's current, what's anticipated?

The Journal of Hospital Infection
A P JohnsonG S Tillotson

Abstract

Changing patterns of pathogens and antibiotic susceptibility present clinicians with difficult choices for antimicrobial prescribing. In particular, multiresistant staphylococci, enterococci and pneumococci present problems in many settings. The number of predictably active antimicrobials is decreasing in many centres, with significant consequences for both patients and society as a whole. New antimicrobial options have been few in recent years and several promising quinolones have been compromised by formulation and/or toxicity issues. Nevertheless, the recent introduction of linezolid and quinupristin/dalfopristin provides clinicians with valuable new options against Gram-positive cocci. These options should further increase with the likely introduction of daptomycin, oritavancin and tigilcycline. A range of surveillance programmes helps monitor the ever-changing patterns of resistance and thus guides clinicians in their empirical prescribing. Empirical use of powerful newer agents may be justifiable in seriously ill patients in those settings, units and countries where there is a substantial background rate of resistance.

References

Aug 1, 1991·The Journal of Infectious Diseases·R MuñozB G Spratt
Oct 1, 1995·Antimicrobial Agents and Chemotherapy·M M ParísG H McCracken
Oct 20, 1998·The Journal of Hospital Infection·A P Johnson
Sep 7, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M B EdmondR P Wenzel
Sep 7, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D F SahmG Piazza
Jan 15, 2000·Lancet·A P Johnson, D M Livermore
Mar 18, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A C FluitJ Verhoef
May 18, 2000·Microbes and Infection·T L Smith, W R Jarvis
Sep 2, 2000·The Journal of Antimicrobial Chemotherapy·R G Masterton
Sep 21, 2000·The Journal of Antimicrobial Chemotherapy·G C SchitoA Marchese
Oct 6, 2000·The Journal of Antimicrobial Chemotherapy·F P Tally, M F DeBruin
Nov 18, 2000·Antimicrobial Agents and Chemotherapy·K T LuhS W Ho
Feb 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E RubinsteinUNKNOWN Linezolid Nosocomial Pneumonia Study Group
Feb 24, 2001·International Journal of Antimicrobial Agents·P C Appelbaum, P A Hunter
Apr 26, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D J HobanR N Jones
Apr 26, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D E LowR N Jones

❮ Previous
Next ❯

Citations

Aug 5, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gary A Noskin
May 24, 2012·Cell and Tissue Banking·R VillalbaJ L Gómez Villagrán
Feb 12, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·D Y Aksoy, S Unal
Feb 11, 2005·The Annals of Pharmacotherapy·Gary E SteinEllie J C Goldstein
Jan 6, 2009·Microbiology and Immunology·Natsumi IshidaMasanori Sasatsu
May 1, 2010·Therapeutic Drug Monitoring·Lucélia Magalhães da Silva, Hérida Regina Nunes Salgado
Jul 26, 2005·The Journal of Antimicrobial Chemotherapy·George A Pankey
Jan 25, 2006·International Journal of Paediatric Dentistry·J L SixouM Bonnaure-Mallet
Jul 25, 2006·Memórias do Instituto Oswaldo Cruz·Angela Cristina Rodrigues GhilardiSueli Aparecida Fernandes
Jul 9, 2003·Annals of Medicine·David M Livermore
Jun 12, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·I A Critchley, J A Karlowsky

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.